Glycostem Chief Development Officer Volker Huppert is going to attend Cell 2023 meeting in London during 07/08 Nov 2023 as a key speaker.

Glycostem Senior Research Manager Anna-Maria Georgoudaki is going to present at the 2nd Cell Therapy Potency Assay Summit in Boston.

Date/Time: 1 June 2023, 16:00-16:30 EDT (GMT-4).

Presentation Title: Maintaining GMP Standards Across Cell Manufacture into Potency Assay Development to Follow a Licensed Approach

• Developing GMP standards for quantitatively testing potency and biological activity
• Setting the expectations of routine potency release testing to GMP standards
• Relating GMP testing and method to the mechanisms of action of the cell therapy 

Glycostem Chief Development Officer Volker Huppert to host an online panel discussion 30^th May as part of the Cell UK Series.

Glycostem Chief Scientific Officer Jan Spanholtz is going to participate and present at the Natural Killer Cell Online Symposium 2023 virtually.

Presentation title: GTA002/oNKord – The Beauty Of Being A Natural Killer

Date/Time: 24 May 2023, 08:50 - 09:10 EDT (UTC -4)

Panel Discussion: NK-Based Therapies: Development, Applications & Challenges

Date/Time: 24 May 2023, 10:30-11:00 EDT (UTC -4)

Glycostem Senior Research Manager Monica Raimo is going to join the 26th ASGCT Annual Meeting from 16-20 May, 2023 in Los Angeles. On Thursday 18 May she is going to have a poster presentation in the conference hall.

Glycostem Chief Development Officer Volker Huppert is going to chair a discussion at the BioProcess International Europe (BPI) 2023 in Amsterdam.

NK Cell Manufacturing: In Process Controls in a Scalable Manufacturing Process

Date and Time: Thursday, 11 May 2023 11:30 - 12:00 CET

Track: Cell & Gene Therapy